Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2013

Sep 17, 2013

34519_dirs_2013-09-17_b552e1bc-27c4-400f-bb95-f569a9208bef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-09-17

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-17 Common Stock, par value $0.10 per share W 39355 Acquired 504635 Direct

Footnotes

F1: This figure includes 214,655 shares of common stock held by Arterio Inc., a corporation owned soley by Mr. Rothschild

F2: This Form 4 is being filed to confirm the status of Mr. Rothschild as a co-executor of his parents' estate. He is a one-third beneficiary of that estate. The distribution of the assets of that estate has not yet been resolved.